克隆相关性作为慢性淋巴细胞白血病Richter转化预后标志物的系统综述
该系统综述检索同行评议文献,纳入15篇手稿共336例患者,其中6项研究以有统计学意义的方式比较克隆相关与克隆不相关Richter转化弥漫大B细胞淋巴瘤的生存结局。2项分析显示两组生存无差异,4项研究报告克隆相关者预后显著更差;作者认为克隆相关性虽与较差生存相关,但尚无研究证明其独立于其他已知临床和基因组变量,需进一步独立验证。
要点
- 15篇手稿共336例患者,仅6项研究对克隆相关与不相关两组生存作有统计学意义的比较。
- 2项分析显示两组生存结局无差异,4项研究报告克隆相关Richter转化弥漫大B细胞淋巴瘤预后显著更差。
- 作者认为克隆相关性虽与较差生存相关,但尚无研究证明其独立于其他已知临床和基因组变量。
核心结论
- 克隆相关性虽与较差生存相关,但尚无研究证明其独立于其他已知影响Richter转化弥漫大B细胞淋巴瘤结局的临床和基因组变量。
- 作者认为需对该预后因素进行进一步独立验证,以助其普遍纳入临床实践。
研究设计与样本
- 系统综述,检索同行评议手稿,纳入考察克隆相关与克隆不相关Richter转化弥漫大B细胞淋巴瘤结局的研究。
- 共纳入15篇手稿、336例患者,其中6项研究以有统计学意义的方式比较两组生存结局。
主要发现
- 2项分析显示克隆相关与克隆不相关两组生存结局无差异。
- 4项研究报告克隆相关Richter转化弥漫大B细胞淋巴瘤预后显著更差。
- 其中2项研究比较两组基线特征,克隆相关病例更多具有TP53 disrupted、IgHV未突变、更重度既往治疗、表达定型B细胞受体VH CDR3,且Richter转化弥漫大B细胞淋巴瘤为MYD88野生型。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者认为需对该预后因素进行进一步独立验证,以助其普遍纳入临床实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The disease shift of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL), so-called Richter transformation (RT), is a catastrophic clinical event. Rarely, survival can outperform expectations and accurate prognostication for patients may affect therapeutic choices. To date, prognosis has relied on readily available factors such as TP53 disruption, previous CLL treatment status, and performance score. Recently, a shared clonality assessment by immunoglobulin heavy-chain variable region gene (IgHV) sequencing of the CLL and RT has been considered therapeutically relevant, but this is infrequently performed. We performed a systematic review of peer-reviewed manuscripts where outcomes in relation to clonal relatedness and lack thereof (clonally related and clonally unrelated RT-DLBCL) were examined. Fifteen manuscripts that included 336 patients were found, of which 6 compared survival outcomes between the 2 groups in a statistically meaningful way. Two analyses showed no difference in survival outcomes with 4 studies reporting a significantly poorer prognosis with clonally related RT-DLBCL. In 2 of these studies, the baseline characteristics of clonally related and clonally unrelated groups were compared and the clonally related cases were enriched for underlying CLL, which was TP53 disrupted, IgHV unmutated, more heavily pretreated, and exhibiting stereotyped B-cell receptor VH CDR3 and RT-DLBCL, which was MYD88 wild type. We demonstrate that although clonal relatedness of the underlying CLL confers a poorer survival, this is not demonstrated in any study to be independent of other well-described clinical and genomic variables known to influence outcomes in RT-DLBCL. Further independent validation of this prognostic factor is required to help guide universal adoption into clinical practice.
引用
- Barrett A, Harris C, Eyre TA, et al. Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review. Blood Adv. 2025. PMID: 40127387. doi:10.1182/bloodadvances.2024015594
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。